Literature DB >> 10750251

The future of NSAID therapy: selective COX-2 inhibitors.

J R Vane, R M Botting.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10750251

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


× No keyword cloud information.
  3 in total

1.  Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam.

Authors:  Manouche Tavakoli
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients.

Authors:  Marc C Hochberg
Journal:  Arthritis Res Ther       Date:  2002-12-11       Impact factor: 5.156

3.  Analgesic and Toxicity Studies of Aminoacetylenic Isoindoline-1,3-dione Derivatives.

Authors:  Raghad Shakir; Zuhair A Muhi-Eldeen; Khalid Z Matalka; Nidal A Qinna
Journal:  ISRN Pharmacol       Date:  2012-12-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.